ICSR Drug Coding Automation (WHODrug + NLP)

Automates a large share of case-level drug coding to reduce manual pharmacovigilance workload Evidence basis: WHODrug Koda evaluation on 4.8 million VigiBase entries reported major automation gains with high coding accuracy; additional NLP work supports scalable coding from unstructured narratives with expert oversight for exceptions

The Problem

ICSR Drug Coding Automation (WHODrug + NLP)

Organizations face these key challenges:

1

Automates a large share of case-level drug coding to reduce manual pharmacovigilance workload

Impact When Solved

Automates a large share of case-level drug coding to reduce manual pharmacovigilance workloadEvidence-backed implementation with human oversight

The Shift

Before AI~85% Manual

Human Does

  • Review each ICSR and identify reported drug names from case details
  • Manually code drugs to WHODrug terms and resolve ambiguous matches
  • Coordinate case follow-up and track coding status in spreadsheets
  • Perform retrospective quality checks and correct coding inconsistencies

Automation

  • No meaningful automation in routine drug coding
  • Limited rule-based lookup support for reference checking
  • Minimal prioritization of cases needing urgent coding attention
With AI~75% Automated

Human Does

  • Review low-confidence or ambiguous coding suggestions and make final coding decisions
  • Approve coded cases that require expert validation before submission
  • Handle exceptions from incomplete narratives, unusual products, or conflicting source data

AI Handles

  • Extract reported drug information from structured fields and unstructured case narratives
  • Match case drugs to WHODrug terms and propose standardized codes at scale
  • Prioritize straightforward cases for rapid processing and flag uncertain cases for review
  • Monitor coding consistency and surface potential discrepancies for human follow-up

Operating Intelligence

How ICSR Drug Coding Automation (WHODrug + NLP) runs once it is live

AI runs the first three steps autonomously.

Humans own every decision.

The system gets smarter each cycle.

Confidence95%
ArchetypeRecommend & Decide
Shape6-step converge
Human gates1
Autonomy
67%AI controls 4 of 6 steps

Who is in control at each step

Each column marks the operating owner for that step. AI-led actions sit above the divider, human decisions and feedback loops sit below it.

Loop shapeconverge

Step 1

Assemble Context

Step 2

Analyze

Step 3

Recommend

Step 4

Human Decision

Step 5

Execute

Step 6

Feedback

AI lead

Autonomous execution

1AI
2AI
3AI
5AI
gate

Human lead

Approval, override, feedback

4Human
6 Loop
AI-led step
Human-controlled step
Feedback loop
TL;DR

AI handles assembly, analysis, and execution. The human gate sits at the decision point. Every cycle refines future recommendations.

The Loop

6 steps

1 operating angles mapped

Operational Depth

Technologies

Technologies commonly used in ICSR Drug Coding Automation (WHODrug + NLP) implementations:

Free access to this report